Most couples have to wait until the second trimester of
pregnancy (4-6 months), but the simple test could cut that time in half—as
early as seven weeks. The test is highly accurate, too. Of the 201 women who
were tested between 2003 and 2009, researchers were able to obtain sufficient
samples from 189 and produce 100 percent accurate results.
When a woman is pregnant, her body will circulate her blood
with blood from the fetus. For this test, a sample of the mother’s blood is
screened for genes unique to the Y-chromosome of males. If these genes were
present, researchers predicted a boy.
Early testing can also help doctors detect conditions such
as Down’s syndrome and Rhesus-D disease (RhD). This method of testing has
several advantages over invasive methods, such as fetal blood sampling (FBS),
that can cause amniotic fluid leaking or miscarriage.
RhD sometimes results from a blood incompatibility between,
for example, an Rh-positive mother and an Rh-negative child. If the mother’s
body detects this difference, it may send antibodies against the baby. If it
goes untreated, it can lead to jaundice, anemia, brain damage or stillbirth.
“Noninvasive
prenatal diagnosis of fetal Rhesus D genotype is sensitive and accurate and has
been widely validated in Europe,” authors noted. “The United States should
begin to undertake clinical trials to bring this technology to patient care as
soon as possible.”
This test is currently not available to the general public, but
continued success could mean it’s on the horizon. Its adoption into general
health practices could help cut the risk of fetal complications of RhD.
The study was published in Obstetrics&Gynecology.
Pancreatic
cancer is a rare form of the disease, accounting for an average of only
29,000 diagnoses in the United States every year. There are more than 42,000
estimated cases this year alone. Pancreatic cancer is difficult to detect,
especially in early stages, and spreads quickly. Symptoms include jaundice,
abdominal pain, bowel obstruction, and weight loss (because the pancreas is
unable to properly metabolize sugar).
Blood type is determined by the ABO gene, found on a region of the 9th chromosome (typically referred to as “region 9”). Glycoproteins are produced in different combinations to determine an individual’s blood type—either A, B, AB, or O. Blood type dictates how sugars are placed on the cell’s surface. In pancreatic tumor cells, this transference is different.
Although it is relatively rare, pancreatic cancer is extremely life threatening because many people are not diagnosed until after it has already spread. Risk is greater for male smokers over the age of 60 with a family history of the disease. According to Pancreatic Cancer Action Network (PanCAN), it is the fourth leading cause of cancer death in the United States, and fewer than 5% of patients survive five years following diagnosis.
The relationship between blood type and pancreatic cancer was first suggested more than half a century ago when research in the 50s and 60s yielded similar results. The results of the study come from Nurses' Health Study and Health Professionals Follow-up Study, associated a 17% greater risk for pancreatic cancer for patients with non-O blood types.
The Pancreatic Cancer Cohort Consortium, an organization of
12 academic medical centers, conducted the study with the help of the National
Cancer Institute. Researchers followed 4,353 individuals with pancreatic cancer
and 4,593 without, using whole-genome scans to detect similar genetic patterns
that may be related to the disease.
“As more variants are discovered and follow-up studies are conducted to examine the biological effects of these variants,” says co-author Stephen J. Chanock, M.D., chief of NCI’s Laboratory of Translational Genomics in DCEG, “a better understanding will emerge of the inherited risk factors and mechanisms that lead to the development of pancreatic cancer."
Both tests showed a greater risk for patients with A and B
blood types. The first of the two experiments in March, 2009, showed that blood
type A had a 32% higher risk, with type AB increasing by 51% and type B
increasing by 72% for risk of pancreatic cancer development.
Co-author Patricia Hartge, Sc.D., also of NCI's Division of Cancer Epidemiology and Genetics, says much more work is needed to better understand the link between blood type and pancreatic cancer: “This finding may lead to improved diagnostic and therapeutic interventions that are so desperately needed."
The study will be published in this month’s online issue of
Nature Genetics. Click here to read the study’s extract, or find more
information about pancreatic cancer.
Connect with others and learn more in our Pancreatic Cancer Community, or take the Healia Cancer Quiz!
Economy
class syndrome also known as deep
venous thrombosis made news a couple of years ago when a British woman died
after a long flight from a blood
clot. At the time one question left unanswered was how often this occurs.
In a new
study, European researchers calculated the risk to be 1 in 4,656. According to
Dr. Samuel Z. Goldhaber, a professor of medicine at
Deep venous
thrombosis is a condition in which a blood clot forms in a vein that is deep
inside the body. This can occur if a person stays in the same position for
prolonged periods; be it on an airplane, in a car, or on a train.
Signs and
symptoms to watch out for while traveling include: leg pain, tenderness or
swelling in your leg, and changes in skin color in your leg.
While there
are no consistently effective preventive measures, you might try:
Search
Healia for more information on economy
class syndrome.
About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site
©2010. Healia / Meredith Corporation
Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.